Clinical Trial

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Cancer
Protocol Amendment History 1 change
notable Trial sites expanded: 1 -> 7 locations 2026-07-14
Trial Details
NCT Number NCT07322094
Lead Sponsor TORL Biotherapeutics, LLC
Conditions FIGO Stage III and IV Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer
Enrollment 60 participants
Start Date 2025-12-10
Primary Completion 2027-12 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-13